We are live on
!
Find out more
Jacobs Levy Equity Management Portfolio holdings
AUM
$23.8B
1-Year Est. Return
25.4%
This Fund
S&P 500
This Quarter
Est. Return
+9.96%
1 Year Est. Return
+25.4%
3 Year Est. Return
+87.35%
5 Year Est. Return
+125.75%
10 Year Est. Return
+515.94%
AUM
$25.2B
AUM Growth
-$335M
(-1.3%)
Cap. Flow
-$2.05B
Cap. Flow
% of AUM
-8.13%
Top 10 Holdings %
Top 10 Hldgs %
26.87%
Holding
1,147
New
127
Increased
298
Reduced
504
Closed
194
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alnylam Pharmaceuticals
ALNY
|
+$160M |
| 2 |
Masco
MAS
|
+$134M |
| 3 |
Lam Research
LRCX
|
+$112M |
| 4 |
Coupang
CPNG
|
+$101M |
| 5 |
Nu Holdings
NU
|
+$98.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
GE Vernova
GEV
|
+$205M |
| 2 |
Lennox International
LII
|
+$191M |
| 3 |
NVIDIA
NVDA
|
+$169M |
| 4 |
Tractor Supply
TSCO
|
+$157M |
| 5 |
Apple
AAPL
|
+$151M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 33.69% |
| 2 | Consumer Discretionary | 12.85% |
| 3 | Industrials | 12.71% |
| 4 | Financials | 12.68% |
| 5 | Healthcare | 9.5% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
676
Emergent Biosolutions
EBS
$377M
| $1.23M | ﹤0.01% |
139,806
-69,167
| -33% | -$538K |
|
|
HTB
677
HomeTrust Bancshares
HTB
$856M
| $1.23M | ﹤0.01% |
30,021
+584
| +2% | +$23.4K |
|
678
Gentherm
THRM
$1.29B
| $1.23M | ﹤0.01% |
+36,011
| New | +$1.22M |
|
679
Northrop Grumman
NOC
$78B
| $1.2M | ﹤0.01% |
1,963
-12,506
| -86% | -$7.09M |
|
680
Atmus Filtration Technologies
ATMU
$4.45B
| $1.19M | ﹤0.01% |
26,444
-398,407
| -94% | -$16.7M |
|
681
Dell
DELL
$253B
| $1.19M | ﹤0.01% |
8,409
+742
| +10% | +$96.3K |
|
682
Peapack-Gladstone Financial
PGC
$846M
| $1.19M | ﹤0.01% |
42,987
-5,413
| -11% | -$152K |
|
|
TLN
683
Talen Energy Corp
TLN
$15.6B
| $1.18M | ﹤0.01% |
2,782
-1,308
| -32% | -$473K |
|
684
Enterprise Financial Services Corp
EFSC
$2.42B
| $1.18M | ﹤0.01% |
20,360
-18,579
| -48% | -$1.08M |
|
|
NSA
685
DELISTED
National Storage Affiliates Trust
NSA
| $1.18M | ﹤0.01% |
38,991
+15,203
| +64% | +$475K |
|
|
DVAX
686
DELISTED
Dynavax Technologies
DVAX
| $1.18M | ﹤0.01% |
118,484
+1,610
| +1% | +$16.8K |
|
687
CubeSmart
CUBE
$9.62B
| $1.18M | ﹤0.01% |
28,899
-6,452
| -18% | -$263K |
|
688
Atea Pharmaceuticals
AVIR
$361M
| $1.16M | ﹤0.01% |
398,423
+107,963
| +37% | +$369K |
|
689
Grand Canyon Education
LOPE
$3.99B
| $1.15M | ﹤0.01% |
5,252
-1,099
| -17% | -$211K |
|
690
Medifast
MED
$108M
| $1.15M | ﹤0.01% |
84,215
-59,037
| -41% | -$825K |
|
691
Carriage Services
CSV
$648M
| $1.14M | ﹤0.01% |
25,556
-51,727
| -67% | -$2.34M |
|
692
Marten Transport
MRTN
$1.25B
| $1.14M | ﹤0.01% |
106,760
-57,533
| -35% | -$700K |
|
693
Guardant Health
GH
$19B
| $1.13M | ﹤0.01% |
18,144
-646
| -3% | -$35.1K |
|
694
RBB Bancorp
RBB
$451M
| $1.13M | ﹤0.01% |
60,106
+12,320
| +26% | +$236K |
|
695
C4 Therapeutics
CCCC
$393M
| $1.12M | ﹤0.01% |
503,145
+61,410
| +14% | +$147K |
|
696
Spok Holdings
SPOK
$228M
| $1.11M | ﹤0.01% |
64,164
-503
| -0.8% | -$8.95K |
|
697
ATN International
ATNI
$370M
| $1.1M | ﹤0.01% |
73,311
-19,275
| -21% | -$319K |
|
|
HTO
698
H2O America
HTO
$2.69B
| $1.08M | ﹤0.01% |
+22,207
| New | +$1.11M |
|
699
AMERISAFE
AMSF
$573M
| $1.08M | ﹤0.01% |
24,658
-15,896
| -39% | -$713K |
|
700
LXP Industrial Trust
LXP
$3.53B
| $1.08M | ﹤0.01% |
24,064
+9,476
| +65% | +$407K |
|
Similar funds
OAG
CHP
SAM
JG
Jacobs Levy Equity Management's Q3 2025 Portfolio in Review
As of Q3 2025, Jacobs Levy Equity Management held 1,147 positions worth $25.2B, down 1.3% from $25.5B the previous quarter. Its ten largest holdings account for 27% of the portfolio.
Jacobs Levy Equity Management withdrew a net $2.05B in Q3 2025, closing 194 positions and reducing 504 holdings. Its most notable exit was Progressive, an estimated $66.7M position sold in full.
By sector, the portfolio is most concentrated in Technology at 34% of assets, up from 32% a quarter earlier, followed by Consumer Discretionary and Industrials.
Against the trend, Jacobs Levy Equity Management opened a new position in Bank of America worth $45M.
- Jacobs Levy Equity Management's largest Q3 2025 buy was Bank of America: 873,228 shares worth $45M.
- Jacobs Levy Equity Management added most to Alnylam Pharmaceuticals in Q3 2025, an estimated $160M increase.
- Jacobs Levy Equity Management's biggest Q3 2025 reduction was GE Vernova, cutting an estimated $205M.
- Jacobs Levy Equity Management fully exited Progressive in Q3 2025, selling an estimated $66.7M.
- Jacobs Levy Equity Management's ten largest holdings make up 27% of its $25.2B portfolio in Q3 2025.
- Jacobs Levy Equity Management opened 127 new positions and closed 194 in Q3 2025.
- Jacobs Levy Equity Management's portfolio value fell 1.3% quarter-over-quarter to $25.2B.
Based on Jacobs Levy Equity Management's 13F filing for Q3 2025, filed 17 Nov 2025.